Fast Market Research recommends "Angion Biomedica Corp. - Product Pipeline Review - 2012" from Global Markets Direct, now available

Boston, MA -- (SBWire) -- 10/26/2012 --Global Markets Direct's pharmaceuticals report, "Angion Biomedica Corp. - Product Pipeline Review - 2012" provides data on the Angion Biomedica Corp.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Angion Biomedica Corp.'s corporate website, SEC filings, investor presentations and featured press releases, both from Angion Biomedica Corp. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Angion Biomedica Corp. - Brief Angion Biomedica Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Angion Biomedica Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Angion Biomedica Corp. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Angion Biomedica Corp.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate Angion Biomedica Corp.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Angion Biomedica Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Angion Biomedica Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Angion Biomedica Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Angion Biomedica Corp. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Angion Biomedica Corp. - Product Pipeline Review - H2 2011
- Stroke - Pipeline Review, H1 2012
- Oxford BioMedica plc - Product Pipeline Review - 2012
- Synta Pharmaceuticals Corp. - Product Pipeline Review - 2012
- Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2012
- Anavex Life Sciences Corp. - Product Pipeline Review - 2012
- Synageva BioPharma Corp. - Product Pipeline Review - 2012
- Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2012
- Ophthotech Corp. - Product Pipeline Review - 2012
- CHONG KUN DANG PHARMACEUTICAL CORP. - Product Pipeline Review - 2012